Redistribution of Fat and Metabolic Change in HIV Infection: Protocol 2 (FRAM Fat 2)

Redistribution and Metabolic Change in HIV Infection: Protocol 2 (FRAM Fat 2)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00244803

Enrollment

101

Registered

2005-10-27

Start date

2005-01-31

Completion date

2007-05-31

Last updated

2016-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Human Immunodeficiency Virus

Keywords

Human Immunodeficiency Virus, FRAM 1

Brief summary

The purpose of this study is to learn whether HIV-infected patients have blood abnormalities which could lead to heart attack or stroke, and to find out what factors may contribute to these abnormalities.

Detailed description

This research is being done to learn whether HIV-infected patients have abnormalities in their blood vessels that could eventually lead to heart attack or stroke (atherosclerosis), in how fat is distributed in their body and in how their body handles fat and sugars. If there are abnormalities, this study will also try to find out what factors may contribute to those abnormalitites. People who participated in FRAM 1 may join FRAM 2.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* 18-65 years old * previous FRAM 1 participant * HIV positive

Exclusion criteria

* Artificial knee or hip replacement or Harrington rod * Metal objects in the body.Pregnancy * Breastfeeding or less than 3 months after breastfeeding * Weight more than 300 pound * On insulin, pancreatic enzymes, or thioridazine.

Countries

United States

Outcome results